Abstract
Nitric oxide (NO), produced from L-arginine by the activity of constitutive and inducible NO synthases, has been implicated in a wide range of physiological and pathophysiological processes. Low concentrations of this mediator play homeostatic roles, whereas NO is up-regulated in a number of pathological states and can have damaging effects. Pharmacological modulation of NO levels or NO biosynthesis may be a therapeutic strategy for a number of conditions, although the reported results can be some times controversial. Inhibitors of NO synthases exhibit different selectivity for the neuronal, endothelial or inducible isoforms, which contributes to their beneficial and detrimental effects. Recent developments in this field may offer an alternative for the treatment of inflammatory disorders, pain, neurological diseases, shock, atherosclerosis or cancer.
Keywords: Nitric oxide (NO), carrageenin, iNOS-transduced, Osteoarthritis, Neurotoxicity, monomethyl-L-arginine (L-NMMA), Tetrahydrobiopterin analogues, Mercaptoethylguanidine, Cyclo-oxygenase, Leukotriene, N-methyl-D-aspartate
Current Pharmaceutical Design
Title: Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task
Volume: 8 Issue: 3
Author(s): M. J. Alcaraz and M. I. Guillen
Affiliation:
Keywords: Nitric oxide (NO), carrageenin, iNOS-transduced, Osteoarthritis, Neurotoxicity, monomethyl-L-arginine (L-NMMA), Tetrahydrobiopterin analogues, Mercaptoethylguanidine, Cyclo-oxygenase, Leukotriene, N-methyl-D-aspartate
Abstract: Nitric oxide (NO), produced from L-arginine by the activity of constitutive and inducible NO synthases, has been implicated in a wide range of physiological and pathophysiological processes. Low concentrations of this mediator play homeostatic roles, whereas NO is up-regulated in a number of pathological states and can have damaging effects. Pharmacological modulation of NO levels or NO biosynthesis may be a therapeutic strategy for a number of conditions, although the reported results can be some times controversial. Inhibitors of NO synthases exhibit different selectivity for the neuronal, endothelial or inducible isoforms, which contributes to their beneficial and detrimental effects. Recent developments in this field may offer an alternative for the treatment of inflammatory disorders, pain, neurological diseases, shock, atherosclerosis or cancer.
Export Options
About this article
Cite this article as:
Alcaraz J. M. and Guillen I. M., Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task, Current Pharmaceutical Design 2002; 8 (3) . https://dx.doi.org/10.2174/1381612023396447
DOI https://dx.doi.org/10.2174/1381612023396447 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?
Current Pharmaceutical Design Tinea Capitis: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Evaluation of Skin Permeability of Resveratrol Loaded Liposomes and Nanostructured Lipid Carriers using a Skin Mimic Artificial Membrane (skin-PAMPA)
Drug Delivery Letters Selective Inhibitors of Nuclear Factor of Activated T Cells: Potential Therapeutic Drugs for the Treatment of Immunological and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes
Current Drug Targets Synthesis and Biological Applications of Triazole Derivatives – A Review
Mini-Reviews in Organic Chemistry Pathophysiology and Prevention of Bronchopulmonary Dysplasia
Current Pediatric Reviews 2015 Update of Erectile Dysfunction Management Following Radical Prostatectomy: From Basic Research to Clinical Management
Current Pharmaceutical Design The Effects of Allergen and Anti-Allergic Drugs on Murine Hemopoietic Cells: Moving Targets, Unusual Mechanisms, and Changing Paradigms
Current Drug Targets - Inflammation & Allergy Imidoyl Radicals in Organic Synthesis
Current Organic Chemistry Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin
Drug Delivery Letters Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Topics in Medicinal Chemistry Modulation of Apoptosis in Acute Ischemic Stroke as Treatment Challenges
Current Immunology Reviews (Discontinued) Discovery of an Unexplored Protein Structural Scaffold of Serine Protease from Big Blue Octopus (Octopus cyanea): A New Prospective Lead Molecule
Current Drug Discovery Technologies Editorial (Thematic Issue: New Mechanisms and Targets for IBD Therapy: Translational Gastroenterology Comes of Age)
Current Drug Targets The Role of Chromogranins and Other Statins in Homeostasis: An Explanation of the Precise Regulation of Glucose and Ionised Calcium in the Blood; An Overview
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents In vivo Near-infrared Fluorescence Tumor Imaging Using DiR-loaded Nanocarriers
Current Drug Delivery Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs γ-Secretase: Structure, Function, and Modulation for Alzheimers Disease
Current Topics in Medicinal Chemistry Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design